Skip to main content
. 2021 Dec 23;8:798571. doi: 10.3389/fmed.2021.798571

Figure 2.

Figure 2

Forest plot showing odds ratios ± 95% confidence intervals of ACE1 polymorphism for developing severea disease in symptomatic COVID-19 cases. Multivariate analysis included variables that were statistically significant in the association analysis shown in Table 2; *P < 0.05. aRated as mild, moderate, or severe according to WHO clinical progression scale for COVID-19 with mild disease as Reference. 1D allele carriers. 2I allele carriers.